Teddy Clinical Research Laboratory

Your Trusted Central Laboratory

As a holding subsidiary of Tigermed (300347.SZ / 3347.HK) that is one of the top listed clinical CRO in China, Teddylab is an one-stop clinical research laboratory service provider dedicated to pharmaceutical companies, biotechs, CROs and research institutions with GCP compliance as well as international standards.

Teddylab is CAP accredited and NGSP Level 1 certified central laboratory. We regularly participate the external quality assessment of China Health Planning Commission and Shanghai Clinical Laboratory Center. Until June the 2024, Teddylab has participated more than 1500 registered clinical trials ranging from phase I to IV. We have worked together with sponsors to pass amount of on-site audits from CFDA and supported the approval of 44 new drugs in China. The therapeutic areas that Teddylab has profound of experience including radiopharmaceutical, immunotherapy, oncology, diabetes, hepatitis, cardiovascular diseases and vaccines.

Moreover, Teddylab also provides a high standard one-stop central laboratory service for international multi regional clinical trials (MRCT) together with our oversea strategic partner central laboratories. Teddylab has supported more than 50 MRCT clinical trials in 10+ theapeutic fields with footprints in 26 countries.

Empower Healthcare Development with Central Laboratory Solutions

10,000 sqm sqm+

Lab Capacity

260 +

Technicians

2000 +

Testing Items

1500 +

Clinical Trials Participated

44 +

NDA Supported

6 +

CAP Accreditations

Snapshot of Shanghai Site

Snapshot of Wuxi Site

Company History

Teddylab is a rapidly growing life science company. We are constantly expanding our global footprints as well as improving our advanced diagnostic technologies and capabilities to fulfill the unmet needs of patients.

2016

Tigermed and DiAn Diagnostic jointly established Teddy Clinical Research Laboratory Shanghai
CAP accredited by the Association of American Pathologists

2017

Teddylab successfully setup routine test and molecular diagnostic labs

2018

Further setup complex technology platforms such as NGS, IHC and flow cytometry
Took the first step in international development by being a partner of Cerba Global Clinical Central Laboratory
Won the title of "Shanghai's Second Batch of High-tech Enterprises 2018"